Jaramillo S, Scherer M, Szu-Tu C, Beneyto-Calabuig S, Müller-Tidow C, Schlenk RF, Hundemer M, Velten L, Pabst C. Late-onset <i>NPM1</i&gt; mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib. Haematologica; https://doi.org/10.3324/haematol.2023.284922 [Early view].